Entospletinib Monotherapy and in Combination With Chemotherapy in Adults With Acute Myeloid Leukemia (AML)
Status:
Terminated
Trial end date:
2019-02-21
Target enrollment:
Participant gender:
Summary
This study will evaluate the efficacy, safety, and tolerability of entospletinib when
administered as monotherapy or in combination with chemotherapy in adults with acute myeloid
leukemia (AML).